Smarter Studies. Global Impact. Better Health.

The MRC Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits.

Latest News and Updates

ICON8 trial shows having chemotherapy every week is no better than having it every three weeks for ovarian cancer

ICON8 was a large international trial looking at whether having smaller doses of chemotherapy more often could help women with epithelial ovarian, fallopian tube, or primary peritoneal cancer. These women are usually tre…

02 Dec

Join our RADICALS and ARTISTIC Twitter Q&A #ProstateRadiotherapy

On Thursday 28 November 2019, we'll be running a Twitter Q&A session about the RADICALS trial and the ARTISTIC meta-analysis - with the hashtag #ProstateRadiotherapy.

21 Nov

The 50th Union World Conference on Lung Health

MRC Clinical Trials Unit at UCL will be presenting results from the STREAM tuberculosis trial.

30 Oct

STAMPEDE provides further insight into treating prostate cancer

Further results from the STAMPEDE trial have been presented at European Society for Medical Oncology Congress 2019 over the last few days

30 Sep

Our Research Themes

Cancer

Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types

Infections

Major international clinical trials answering questions of global public health significance

Methodology

Development of methods with direct impact on the design, conduct and analysis of studies

Other Research & Policy

This section will capture projects outside the current QQR themes